Patterson Companies (NASDAQ:PDCO) Stock Rating Reaffirmed by Credit Suisse Group

Patterson Companies (NASDAQ:PDCO)‘s stock had its “buy” rating restated by investment analysts at Credit Suisse Group in a note issued to investors on Monday, AnalystRatings.com reports.

PDCO has been the topic of a number of other reports. BidaskClub downgraded shares of Patterson Companies from a “strong-buy” rating to a “buy” rating in a research report on Thursday, June 18th. Goldman Sachs Group raised shares of Patterson Companies from a “sell” rating to a “neutral” rating and raised their price objective for the company from $11.00 to $21.00 in a research note on Thursday, June 25th. UBS Group lifted their target price on shares of Patterson Companies from $20.00 to $21.00 and gave the stock a “neutral” rating in a report on Friday, June 26th. Barclays reissued a “sell” rating and issued a $16.00 price target on shares of Patterson Companies in a research note on Friday, March 20th. Finally, ValuEngine raised Patterson Companies from a “sell” rating to a “hold” rating in a research note on Friday, May 1st. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $22.11.

Shares of PDCO stock opened at $22.00 on Monday. The company has a current ratio of 1.41, a quick ratio of 0.69 and a debt-to-equity ratio of 0.44. The firm has a market capitalization of $2.19 billion, a price-to-earnings ratio of -3.53, a PEG ratio of 2.50 and a beta of 1.53. The firm’s 50 day moving average is $18.87 and its 200-day moving average is $19.67. Patterson Companies has a 1 year low of $12.93 and a 1 year high of $25.70.

Patterson Companies (NASDAQ:PDCO) last released its earnings results on Wednesday, June 24th. The company reported $0.43 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.17 by $0.26. Patterson Companies had a positive return on equity of 9.99% and a negative net margin of 10.72%. The company had revenue of $1.29 billion during the quarter, compared to analysts’ expectations of $1.17 billion. During the same period last year, the firm earned $0.37 EPS. The business’s revenue for the quarter was down 10.5% on a year-over-year basis. On average, equities research analysts forecast that Patterson Companies will post 1.34 earnings per share for the current fiscal year.

Institutional investors have recently modified their holdings of the stock. Cubist Systematic Strategies LLC grew its stake in Patterson Companies by 0.5% in the fourth quarter. Cubist Systematic Strategies LLC now owns 125,525 shares of the company’s stock valued at $2,571,000 after acquiring an additional 627 shares during the period. Crossmark Global Holdings Inc. raised its position in shares of Patterson Companies by 3.3% during the first quarter. Crossmark Global Holdings Inc. now owns 19,700 shares of the company’s stock worth $301,000 after purchasing an additional 630 shares during the period. Mason Street Advisors LLC lifted its stake in Patterson Companies by 1.6% in the fourth quarter. Mason Street Advisors LLC now owns 45,821 shares of the company’s stock valued at $938,000 after buying an additional 723 shares in the last quarter. O Shares Investment Advisers LLC raised its holdings in shares of Patterson Companies by 2.0% during the fourth quarter. O Shares Investment Advisers LLC now owns 48,226 shares of the company’s stock worth $988,000 after acquiring an additional 959 shares during the period. Finally, Federated Hermes Inc. lifted its position in Patterson Companies by 8.4% in the 1st quarter. Federated Hermes Inc. now owns 13,300 shares of the company’s stock valued at $203,000 after acquiring an additional 1,027 shares in the last quarter. 88.04% of the stock is currently owned by institutional investors and hedge funds.

Patterson Companies Company Profile

Patterson Companies, Inc distributes and sells dental and animal health products in the United States, the United Kingdom, and Canada. It operates through Dental and Animal Health segments. The company's Dental segment offers consumable products, such as infection control, restorative materials, hand instruments, and sterilization products; basic and advanced technology dental equipment; patient education systems; and office forms and stationery.

Read More: Limitations of analyzing profit margin

Analyst Recommendations for Patterson Companies (NASDAQ:PDCO)

Receive News & Ratings for Patterson Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Patterson Companies and related companies with MarketBeat.com's FREE daily email newsletter.